MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

BACKGROUND: Midregional proadrenomedullin (MR‐proADM) has demonstrated prognostic potential after myocardial infarction (MI). Yet, the prognostic value of MR‐proADM at admission has not been examined in patients with ST‐segment–elevation MI (STEMI). METHODS AND RESULTS: The aim of this substudy, DAN...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Am Heart Assoc
Main Authors: Falkentoft, Alexander C., Rørth, Rasmus, Iversen, Kasper, Høfsten, Dan E., Kelbæk, Henning, Holmvang, Lene, Frydland, Martin, Schoos, Mikkel M., Helqvist, Steffen, Axelsson, Anna, Clemmensen, Peter, Jørgensen, Erik, Saunamäki, Kari, Tilsted, Hans‐Henrik, Pedersen, Frants, Torp‐Pedersen, Christian, Kofoed, Klaus F., Goetze, Jens P., Engstrøm, Thomas, Køber, Lars
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2018
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015359/
https://ncbi.nlm.nih.gov/pubmed/29776961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008123
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍